Dr. Weinberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 800-789-7366Fax+1 215-349-5915
Summary
- Dr. Ethan Weinberg is a Gastroenterologist based in Philadelphia, PA, with subspecialties in Hepatology and Liver Transplantation. He graduated from the University of Maryland School of Medicine in 2009 and completed his residency in Internal Medicine at New York Presbyterian Hospital (Cornell Campus). He also holds an AB from Princeton University and a MS in Clinical Investigation from Rockefeller University. His experience spans various aspects of hepatology, including hepatic encephalopathy, hepatitis B and C, and non-alcoholic fatty liver disease. Significant contributions from Dr. Weinberg to medical literature include several papers published in reputed journals like Hepatology, Gastroenterology & Hepatology, and Contemporary Clinical Trials Communications. He's also conducted clinical trials on prevention of falls in patients with cirrhosis, the effects of Zetomipzomib on autoimmune hepatitis, and severe alcohol-associated hepatitis.
Education & Training
- Rockefeller UniversityMS, Clinical Investigation, 2016
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2012
- University of Maryland School of MedicineClass of 2009
- University of MarylandMD, 2009
- Princeton UniversityAB, 2003
Certifications & Licensure
- PA State Medical License 2016 - 2026
- NY State Medical License 2011 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) Start of enrollment: 2023 May 23
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis Start of enrollment: 2023 Jun 13
- FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study Start of enrollment: 2022 Dec 15
Publications & Presentations
PubMed
- 1 citationsReal-world evidence for factors associated with maintenance treatment practices among US adults with autoimmune hepatitis.Therese Bittermann, Lina Yagan, Ranganath G Kathawate, Ethan M Weinberg, Eliot G Peyster
Hepatology. 2025-02-01 - 2 citationsNovel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.Jacqueline V Scott, Jude Moutchia, Robin L McClelland, Nadine Al-Naamani, Ethan Weinberg
American Journal of Respiratory and Critical Care Medicine. 2024-10-15 - Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.K Rajender Reddy, Ethan M Weinberg, Stevan A Gonzalez, Manhal J Izzy, Douglas A Simonetto
Liver Transplantation. 2024-10-01
Press Mentions
- PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024
- PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: